Arecor Therapeutics (AREC) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Aug 2022 02:09 PM
RNS
Holding(s) in Company
04 Aug 2022 02:08 PM
RNS
Holding(s) in Company
04 Aug 2022 10:45 AM
RNS
Holding(s) in Company
04 Aug 2022 08:55 AM
RNS
Director/PDMR Dealings
02 Aug 2022 04:52 PM
RNS
Arecor on Investor Meet Company Platform
01 Aug 2022 02:46 PM
RNS
Result of Placing
01 Aug 2022 07:00 AM
RNS
Proposed Acquisition of Tetris Pharma Ltd
14 Jul 2022 07:00 AM
RNS
BUSINESS UPDATE
04 Jul 2022 07:00 AM
RNS
ARECOR ANNOUNCES PRESENTATION AT EASD 2022
16 Jun 2022 07:00 AM
RNS
ARECOR COLLABORATES WITH TOP GLOBAL PHARMA COMPANY
23 May 2022 02:19 PM
RNS
RESULT OF AGM
23 May 2022 07:00 AM
RNS
Arecor AGM statement
18 May 2022 08:00 AM
RNS
ARECOR TO HOST KOL WEBINAR
28 Apr 2022 07:00 AM
RNS
ARECOR PRESENTS AT278 PHASE I DATA AT ATTD MEETING
27 Apr 2022 05:08 PM
RNS
ARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM
27 Apr 2022 07:00 AM
RNS
Arecor on Investor Meet Company Platform
25 Apr 2022 07:00 AM
RNS
FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
12 Apr 2022 07:00 AM
RNS
ARECOR ANNOUNCES ORAL PRESENTATION AT ATTD 2022
29 Mar 2022 07:00 AM
RNS
Notice of Preliminary Results
28 Mar 2022 07:00 AM
RNS
Arecor wins at CambridgeshireLive Business Awards
23 Mar 2022 07:00 AM
RNS
Arecor Granted Key U.S Patent
20 Jan 2022 07:01 AM
RNS
ARECOR PROVIDES BUSINESS UPDATE
20 Jan 2022 07:00 AM
RNS
ARECOR COMMENCES US PHASE I TRIAL OF AT247
21 Dec 2021 07:00 AM
RNS
Arecor Provides Update on Agreement with Hikma
14 Dec 2021 07:00 AM
RNS
Arecor Collaborates with Global Technology Leader
25 Nov 2021 07:00 AM
RNS
Grant of Options, PDMR Dealing
11 Nov 2021 07:00 AM
RNS
Holdings in Company
11 Nov 2021 07:00 AM
RNS
Arecor Granted Key Canadian Patent
01 Nov 2021 07:00 AM
RNS
Arecor announces formulation study collaboration
25 Oct 2021 04:25 PM
RNS
Exercise of options, PDMR, Total Voting Rights
11 Oct 2021 09:18 AM
RNS
Arecor's Polysaccharide Vaccine Patent Upheld
23 Sep 2021 07:00 AM
RNS
INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2021
22 Sep 2021 04:41 PM
RNS
Second Price Monitoring Extn
22 Sep 2021 04:36 PM
RNS
Price Monitoring Extension
22 Sep 2021 02:06 PM
RNS
Second Price Monitoring Extn
22 Sep 2021 02:00 PM
RNS
Price Monitoring Extension
22 Sep 2021 11:06 AM
RNS
Second Price Monitoring Extn
22 Sep 2021 11:00 AM
RNS
Price Monitoring Extension
22 Sep 2021 09:06 AM
RNS
Second Price Monitoring Extn
22 Sep 2021 09:00 AM
RNS
Price Monitoring Extension
20 Sep 2021 02:05 PM
RNS
Second Price Monitoring Extn
20 Sep 2021 02:00 PM
RNS
Price Monitoring Extension
20 Sep 2021 07:00 AM
RNS
Positive results for AT278 clinical trial
09 Sep 2021 07:00 AM
RNS
FDA clearance of IND
07 Sep 2021 07:00 AM
RNS
EXCLUSIVE COLLABORATION WITH INTAS PHARMACEUTICALS
03 Sep 2021 07:00 AM
RNS
Notice of Interim Results
27 Aug 2021 01:40 PM
RNS
APPOINTMENT OF GRANT THORNTON AS AUDITOR
14 Jul 2021 07:00 AM
RNS
Business Update
29 Jun 2021 12:05 PM
RNS
Director Dealing
10 Jun 2021 07:00 AM
RNS
APPOINTS DR. LINDSEY FOULKES AS COO
UK 100

Latest directors dealings